Emcure Pharma: Low- to Mid-teen Growth for FY26-27
Moneylife Digital Team 19 May 2026
Emcure Pharmaceuticals Limited (Emcure) is transitioning from a predominantly acute and tender-led generics profile to a more balanced platform of chronic, specialty and complex therapies. The...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
SINGLE ARTICLE
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
 
Get access to complete archives
Rs 5000 + GST
 
 
Already a subscriber ? Log in
Market This Week
Moneylife Digital Team 15 May 2026
Moneylife’s market breadth indicators slipped back into neutral territory this week after nearly three weeks in a bullish phase, reflecting the continuation of weakening trends. The proportion of stocks sustaining above key moving...
Weekly Moneylife Indices & Sector Trends
Moneylife Digital Team 15 May 2026
INDIAN MARKET TRENDS From 8th May to 14 May 2026, ML Micro-cap Index fell 1%. ML Mega-cap Index fell 2%. The NIFTY and the Sensex fell 2% each. ML Small-cap Index fell 4%. ML Large-cap Index and ML Mid-cap Index fell 4% each.      ...
Moneylife Stockgraders
Moneylife Digital Team 15 May 2026
Guidelines                                        1. The Grader captures the three factors that determine investments: valuation, returns and price strength. Our grader captures these three parameters.   2. In this system, A is a...
Vimta Labs Bets on Biologics To Drive the Next Phase of Growth
Moneylife Digital Team 15 May 2026
Vimta Labs Limited (Vimta) was established in 1984 and provides contract research and testing services to pharmaceuticals, food, electronics and environmental industries. The company operates 10 laboratories and offices across India,...
Free Helpline
Legal Credit
Feedback